V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002812 | 240005442 | 1.6 | 85.3 | Curative (C) | 2019-08-01 | 2019-08-15 | null | 02 | null | MELPHALAN | 101468213 |
| 240002813 | 240005443 | 1.5 | 84 | Palliative (P) | 2017-10-09 | 2018-01-04 | null | 01 | null | DA | 100396761 |
| 240002815 | 240005444 | 1.67 | 86 | 03 | 2019-12-05 | 2019-12-09 | Cytarabine High Dose | 02 | null | IBRUTINIB | 100137843 |
| 240002816 | 240005445 | 1.76 | 25.55 | null | null | 2019-01-06 | null | null | null | ANAGRELIDE | 100165288 |
| 240002817 | 240005446 | 1.83 | 72.5 | null | 2018-07-09 | 2018-07-27 | null | 02 | null | FLAIR TRIAL | 100255854 |
| 240002819 | 240005448 | 1.85 | 112.9 | null | 2016-01-17 | 2016-05-13 | FLUDARABINE + THIOTEPA + TREOSULFAN | 02 | null | AML MYECHILD 01 IT CYT | 100415342 |
| 240002820 | 240005449 | 1.68 | 91.4 | null | 2016-11-26 | 2019-10-27 | IVE | 01 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 100058537 |
| 240002823 | 240005451 | 0 | 55 | null | 2019-04-29 | 2019-04-30 | ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx | 02 | null | DA | 101089823 |
| 240002824 | 240005452 | 1.72 | 60.5 | Curative (C) | null | 2019-08-20 | null | null | null | CYTARABINE + DAUNORUBICIN | 101276743 |
| 240002825 | 240005453 | 1.66 | 61 | Curative (C) | 2016-07-19 | 2016-08-03 | IMATINIB | Y | null | ALL UKALL2011 CAP INT MAINT C | 100345964 |
| 240002826 | 240005454 | 0.83 | 69.8 | null | null | 2018-08-11 | ALL UKALL2011 Maintenance A1 | null | null | AML MYECHILD 01 FLA-IDARUBICIN | 101539970 |
| 240002827 | 240005455 | 1.65 | 80 | null | 2017-11-08 | 2017-12-02 | null | 02 | null | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100850823 |
| 240002828 | 240005456 | 1.63 | 21 | null | 2019-02-22 | 2019-02-22 | ALL Interim Guide 2019 Maintenance | 02 | null | GILTERITINIB | 101370497 |
| 240002829 | 240005457 | 1.66 | 32.05 | Curative (C) | null | 2019-04-15 | null | null | N | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE | 101182933 |
| 240002830 | 240005458 | 1.75 | 45.1 | null | 2019-05-20 | 2019-05-27 | null | 02 | null | AML INTERIM GUIDELINES FLAG-IDA | 100893645 |
| 240002831 | 240005459 | 1.73 | 0 | Palliative (P) | 2016-11-23 | 2016-11-25 | null | 02 | N | DA | 100005624 |
| 240002832 | 240005460 | 1.83 | 51.6 | Curative (C) | 2021-04-07 | 2021-04-09 | Dasatinib | N | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101387929 |
| 240002833 | 240005461 | 1.76 | 91.8 | Curative (C) | 2021-12-15 | 2021-12-17 | Methotrexate High Dose (3g/m2) | 02 | null | BUSULFAN | 100879286 |
| 240002834 | 240005462 | 1.79 | 73.7 | Palliative (P) | 2018-06-01 | 2018-06-04 | IVAC | 02 | N | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100483301 |
| 240002837 | 240005464 | null | 87.3 | Disease modification (D) | 2017-02-24 | 2017-03-30 | DA-EPOCH-R | 02 | N | PEG INTERFERON | 100702005 |
| 240002840 | 240005467 | 1.85 | 73.4 | Palliative (P) | 2018-12-06 | 2019-01-19 | GEM-P | 01 | null | FLAIR TRIAL | 101715283 |
| 240002842 | 240005469 | 1.69 | 69.1 | null | null | 2016-05-17 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | null | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 100854412 |
| 240002844 | 240005471 | 0 | 96.8 | null | 2019-05-20 | 2019-05-23 | BORTEZOMIB + THALIDOMIDE | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100157504 |
| 240002845 | 240005472 | 1.65 | 37.2 | Curative (C) | 2016-07-20 | 2016-07-20 | Etoposide oral | 02 | null | CYCLOPHOSPHAMIDE | 101713235 |
| 240002846 | 240005473 | null | null | Curative (C) | null | 2020-12-01 | FLAIR trial | null | N | RUXOLITINIB | 100462976 |
| 240002850 | 240005477 | 0 | null | 03 | 2018-02-07 | 2018-02-09 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100515852 |
| 240000049 | 240005478 | 1.75 | 101.5 | Curative (C) | 2019-09-03 | 2019-09-25 | null | 01 | null | CLOFARABINE + CYTARABINE | 101002798 |
| 240000200 | 240005482 | 1.56 | 70 | null | 2016-07-25 | 2016-07-25 | RUXOLITINIB | 02 | null | APML RELAPSE REINDUCTION ATO | 100986903 |
| 240000220 | 240005483 | 1.72 | 82.6 | null | 2018-07-06 | 2018-07-06 | null | 02 | N | FLAIR TRIAL | 100087767 |
| 240000237 | 240005484 | 1.83 | 8.6 | 03 | 2019-01-18 | 2019-01-27 | CYTARABINE + FLUDARABINE | 02 | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100510652 |
| 240000288 | 240005485 | 1.6 | 55.9 | null | 2018-12-02 | 2019-11-30 | CYCLOPHOSPHAMIDE + FLUDARABINE | 01 | Y | TRIPLE INTRATHECAL | 100026639 |
| 240000326 | 240005486 | 1.85 | 62.8 | 03 | null | 2021-06-03 | ALL UKALL2011 Aug BFM Cons C PegAsp | null | N | CARBOPLATIN + VINCRISTINE | 100557035 |
| 240000346 | 240005487 | 1.7 | 92.35 | Curative (C) | null | 2018-08-31 | FLAG + Idarubicin | Y | null | ALL UKALL2011 DEL INT A | 100061416 |
| 240000359 | 240005488 | 1.66 | 56 | null | 2019-12-26 | 2019-12-26 | IBRUTINIB | 01 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100257248 |
| 240000434 | 240005490 | 1.68 | 0 | Curative (C) | 2018-12-18 | 2018-12-20 | Cyclophosphamide High Dose | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100244785 |
| 240000443 | 240005491 | 1.76 | 60 | Curative (C) | 2019-02-14 | 2019-03-27 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | IBRUTINIB | 100116826 |
| 240000506 | 240005492 | 0 | 20 | null | 2017-09-16 | 2019-05-06 | FLAIR trial | N | null | PEG INTERFERON | 100084458 |
| 240000531 | 240005493 | 0 | 27.8 | null | 2019-10-19 | 2019-10-19 | null | 02 | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101063988 |
| 240000533 | 240005494 | 1.74 | 77.75 | 03 | 2019-11-17 | 2019-11-19 | null | N | null | CYCLOPHOSPHAMIDE | 100823555 |
| 240000612 | 240005496 | 1.74 | 55.2 | 03 | null | 2018-07-26 | null | null | N | TRANSPLANT CAR-T CELLS - AXICABTAGENE CILOLEUCEL | 101716921 |
| 240000626 | 240005498 | 1.76 | 77 | Curative (C) | 2017-08-17 | 2017-08-25 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 01 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 101019381 |
| 240000718 | 240005500 | 1.62 | 60 | Adjuvant (A) | 2017-07-18 | 2017-07-20 | Cytarabine High Dose | 02 | N | ETOPOSIDE | 100996040 |
| 240000738 | 240005501 | 0 | 0 | null | 2018-10-29 | 2018-11-03 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | null | ANAGRELIDE | 100312022 |
| 240000877 | 240005504 | 1.65 | 13.9 | Curative (C) | null | 2018-06-09 | null | null | null | ALL INT GDE 2019 MAINTENANCE | 100225439 |
| 240000957 | 240005506 | 1.85 | 67.9 | Curative (C) | 2019-02-18 | 2019-02-24 | Venetoclax | 02 | N | ALL INT GDE 2019 CONSOLIDATION A | 100748661 |
| 240000970 | 240005508 | 1.6 | null | null | 2019-06-04 | 2019-06-09 | Vinblastine | 02 | null | CYCLOPHOSPHAMIDE | 100916897 |
| 240001015 | 240005509 | 1.8 | 85.3 | null | 2016-05-31 | 2016-06-03 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 101156464 |
| 240001123 | 240005511 | 1.64 | 53.3 | null | 2019-05-22 | 2019-05-24 | DTPACE | 02 | null | VENETOCLAX | 101055953 |
| 240001189 | 240005512 | 1.6 | null | null | null | 2018-10-21 | IBRUTINIB | null | null | RUXOLITINIB | 101530642 |
| 240001287 | 240005513 | null | null | 03 | null | 2017-05-23 | IBRUTINIB | N | null | BENDAMUSTINE | 100843054 |